Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents – a Berlin–Frankfurt–Münster group report
Authors:
- 10 February 2006
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 133 (2) , 176-182
Abstract
Summary: Patients with refractory or early relapsed anaplastic large cell lymphoma (ALCL) have a poor chance of survival. We report 20 children and adolescents with high‐risk relapsed or refractory ALCL who underwent allogeneic haematopoietic stem cell transplantation (HSCT). We retrospectively analysed 20 patients who relapsed between December 1991 and April 2003 during (six patients) or soon after first‐line Berlin–Frankfurt–Münster‐type chemotherapy (14 patients) and underwent allogeneic HSCT. Nine patients received allogeneic HSCT after the first relapse and 11 after multiple relapses. Eight patients received their transplants from matched sibling donors, eight from unrelated donors and four from haploidentical family donors. The conditioning regimen was based on total body irradiation in 15 patients. Two patients relapsed after allogeneic HSCT and died. Three patients died of transplant‐related toxicity. Event‐free survival at 3 years after allogeneic transplant was 75 ± 10%. There was no influence of donor type or conditioning regimen on outcome. Two of six patients with progressive disease during frontline therapy survived compared with 13/14 patients with a first relapse after frontline therapy. Two of three patients who were transplanted with active lymphoma and all five patients who received allogeneic HSCT for relapse following autologous HSCT survived disease‐free. Allogeneic HSCT is effective and has acceptable toxicity as rescue therapy for high‐risk ALCL relapse. It even offers cure for patients refractory to chemotherapy, suggesting a graft‐versus‐ALCL effect.Keywords
This publication has 14 references indexed in Scilit:
- The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95Blood, 2004
- Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphomaThe Lancet Oncology, 2004
- Anaplastic large cell lymphoma in Japanese children: retrospective analysis of 34 patients diagnosed at the National Research Institute for Child Health and DevelopmentBritish Journal of Haematology, 2003
- Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimensBritish Journal of Haematology, 2002
- Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90Blood, 2001
- Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantationExperimental Hematology, 2001
- Relapses of childhood anaplastic large-cell lymphoma: Treatment results in a series of 41 children - a report from the French Society of Pediatric OncologyAnnals of Oncology, 2000
- Transplantation of Megadoses of Purified Haploidentical Stem CellsAnnals of the New York Academy of Sciences, 1999
- Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT)Bone Marrow Transplantation, 1999
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958